Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
The Trouble With KRAS - Cancer Commons
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Colorectal Cancer
Mapping the KRAS Proteoform in Colorectal Cancer - MagLab
Full article: Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar
APMG Colon Molecular Pathways
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
KRAS Biomarker | Colorectal Cancer Alliance
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
The mutation distribution of KRAS/NRAS/BRAF in (A) colon cancer, (B)... | Download Scientific Diagram
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
